| SFDA Approved Use |
a) the control of hypertension;
b) the management of angina pectoris; c) long term management against re-infarction after recovery from acute myocardial infarction; d) the control of most forms of cardiac dysrhythmias; e) the prophylaxis of migraine; f) the management of essential tremor; g) relief of situational anxiety and generalised anxiety symptoms, particularly those of somatic type; h) prophylaxis of upper gastrointestinal bleeding in patients with portal hypertension and oesophageal varices; i) the adjunctive management of thyrotoxicosis and thyrotoxic crisis; j) management of hypertrophic obstructive cardiomyopathy; k) management of phaeochromocytoma peri-operatively (with an alpha-blocker). |
|---|
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 25 Jun 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.